Table 1. Search strategies for publications on cotrimoxazole’s effect on mortality and morbidity in adults with human immunodeficiency virus (HIV) infection receiving antiretroviral therapy (ART).
| Search number | PubMed search terms | Search number | Embase search terms |
|---|---|---|---|
| 1 | HIV infections (MeSH term) | 1 | HIV |
| 2 | Acquired immunodeficiency syndrome (MeSH term) | 2 | AIDS |
| 3 | AIDS-related opportunistic infections (MeSH term) | 3 | Terms used in search 1 or 2 |
| 4 | AIDS | 4 | Antiretroviral |
| 5 | HIV | 5 | Anti-retroviral |
| 6 | Terms used in search 1 or 2 or 3 or 4 or 5 | 6 | HAART |
| 7 | Antiretroviral therapy, highly active (MeSH term) | 7 | cART |
| 8 | Anti-infective agents (MeSH term) | 8 | ART |
| 9 | Antiretroviral | 9 | Terms used in search 4 or 5 or 6 or 7 or 8 |
| 10 | Anti-retroviral | 10 | Cotrimoxazole |
| 11 | HAART | 11 | Co-trimoxazole |
| 12 | ART | 12 | CPT |
| 13 | cART | 13 | Trimethoprim-sulfamethoxazole |
| 14 | Terms used in search 7 or 8 or 9 or 10 or 11 or 12 or 13 | 14 | Sulfamethoxazole-trimethoprim |
| 15 | Trimethoprim-sulfamethoxazole combination (MeSH term) | 15 | Terms used in search 10 or 11 or 12 or 13 or 14 |
| 16 | Cotrimoxazole | 16 | Mortality |
| 17 | Co-trimoxazole | 17 | Death |
| 18 | CPT | 18 | Hospitalization |
| 19 | Terms used in search 15 or 16 or 17 or 18 | 19 | Adverse event |
| 20 | Mortality (MeSH term) | 20 | Terms used in search 16 or 17 or 18 or 19 |
| 21 | Death (MeSH term) | 21 | Terms used in searches 3 and 9 and 15 and 20 |
| 22 | Hospitalization (MeSH term) | ||
| 23 | Mortality | ||
| 24 | Death | ||
| 25 | Hospitalization | ||
| 26 | Adverse event | ||
| 27 | Terms used in search 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 | ||
| 28 | Terms used in searches 6 and 14 and 19 and 27 |
AIDS, acquired immunodeficiency syndrome; cART, combination antiretroviral therapy; CPT, cotrimoxazole preventive therapy; HAART, highly active antiretroviral therapy; MeSH, medical subject heading.